 |
 |

Aggressive Lipid-Lowering Therapy and Regression of Coronary Atheroma
 |
 |
| Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings. |
|
 |
 |
To the Editor: Dr Nissen and colleagues1 argued that either total cholesterol or LDL cholesterol should be lowered as much as possible to prevent coronary heart disease. I disagree with this conclusion for several reasons.
First, the study was limited to patients with significant coronary heart disease. Second, pravastatin and atorvastatin have different effects on other relevant factors.2 Third, a comparison was made only between moderate and extensive cholesterol lowering. Fourth, no dose-response relationship was noted for end points such as myocardial infarction or coronary mortality.
Although the authors found a correlation with lipid-lowering changes in plaque (using an intravascular ultrasound technique), this may have resulted from other effects of statins, such as reduction of inflammation or other effects on atherosclerosis rather than from lipid lowering.3 In fact, a dose-response relationship between degree of cholesterol lowering and outcome has not been demonstrated in most clinical and angiographic trials of statins.4 . . . [Full Text of this Article]
Paul J. Rosch, MD
stress124@optonline.net Yonkers, NY
CiteULike Connotea Del.icio.us Digg Reddit Technorati Twitter
What's this?
RELATED ARTICLES
Aggressive Lipid-Lowering Therapy and Regression of Coronary Atheroma
Uffe Ravnskov and Morley C. Sutter
JAMA. 2004;292(1):38.
EXTRACT
| FULL TEXT
Aggressive Lipid-Lowering Therapy and Regression of Coronary Atheroma
Kavitha Rajaram
JAMA. 2004;292(1):39.
EXTRACT
| FULL TEXT
Aggressive Lipid-Lowering Therapy and Regression of Coronary Atheroma
Pim van der Harst, Wiek H. van Gilst, and Felix Zijlstra
JAMA. 2004;292(1):39.
EXTRACT
| FULL TEXT
Aggressive Lipid-Lowering Therapy and Regression of Coronary AtheromaReply
Steven Nissen and For the REVERSAL Investigators
JAMA. 2004;292(1):39-40.
EXTRACT
| FULL TEXT
Effect of Intensive Compared With Moderate Lipid-Lowering Therapy on Progression of Coronary Atherosclerosis: A Randomized Controlled Trial
Steven E. Nissen, E. Murat Tuzcu, Paul Schoenhagen, B. Greg Brown, Peter Ganz, Robert A. Vogel, Tim Crowe, Gail Howard, Christopher J. Cooper, Bruce Brodie, Cindy L. Grines, and Anthony N. DeMaria
JAMA. 2004;291(9):1071-1080.
ABSTRACT
| FULL TEXT
|